NOHO PARTNERS PLC FINANCIAL STATEMENTS RELEASE 1 JANUARY – 31 DECEMBER 2020: The year of COVID-19 caused an operating loss of MEUR 24 – following structural changes and a new financing agreement, the company prepares for a rebuilding phase

NEXT STORY
Medical Gloves Market Trends | North America, Europe, & APAC Industry Forecasts 2020-2026: Graphical Research
PREV STORY
Press news Biocartis Group NV: BIOCARTIS ANNOUNCES 2020 FULL YEAR RESULTS ON 25 FEBRUARY 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

NOHO PARTNERS PLC FINANCIAL STATEMENTS RELEASE 1 JANUARY – 31 DECEMBER 2020: The year of COVID-19 caused an operating loss of MEUR 24 – following structural changes and a new financing agreement, the company prepares for a rebuilding phase

NEXT STORY
Medical Gloves Market Trends | North America, Europe, & APAC Industry Forecasts 2020-2026: Graphical Research
PREV STORY
Press news Biocartis Group NV: BIOCARTIS ANNOUNCES 2020 FULL YEAR RESULTS ON 25 FEBRUARY 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Enzymatica AB: Bulletin from extraordinary general meeting in Enzymatica AB (publ)

Today on 19 December 2016 at Enzymatica's extraordinary general meeting in Lund, the meeting ...

author_avatar
NASDAQ Market News

Novan Announces Closing of $40 Million Public Offering of Common Stock

author_avatar
NASDAQ Market News

Mersana Strengthens Board of Directors Leadership with Appointment of Willard H. Dere, M.D., Professor at the University of Utah and Retired Chief Medical Officer of Amgen

CAMBRIDGE, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage ...

author_avatar
NASDAQ Market News